
Education and Training
- Fellowship in Nephrology, Medicine, Duke University School of Medicine, 2013 - 2016
- Internal Medicine Residency, Medicine, Duke University School of Medicine, 2010 - 2013
- M.D., Loma Linda University, School of Medicine, 2010
Drake, Connor, Tyler Lian, Blake Cameron, Kate Medynskaya, Hayden B. Bosworth, and Kevin Shah. “Understanding Telemedicine's "New Normal": Variations in Telemedicine Use by Specialty Line and Patient Demographics.” Telemed J E Health 28, no. 1 (January 2022): 51–59. https://doi.org/10.1089/tmj.2021.0041.
Foster, Gena G., Michael J. Grant, Samantha M. Thomas, Blake Cameron, Doug Raiff, Kelly Corbet, Gavin Loitsch, Christopher Ferreri, and Mitchell Horwitz. “Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function.” Biol Blood Marrow Transplant 26, no. 9 (September 2020): 1597–1606. https://doi.org/10.1016/j.bbmt.2020.05.007.
Lunyera, Joseph, Dinushika Mohottige, Anastasia-Stefania Alexopoulos, Hilary Campbell, C Blake Cameron, Nicole Sagalla, Timothy J. Amrhein, et al. “Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.” Ann Intern Med 173, no. 2 (July 21, 2020): 110–19. https://doi.org/10.7326/M20-0299.
Wosik, Jedrek, Marat Fudim, Blake Cameron, Ziad F. Gellad, Alex Cho, Donna Phinney, Simon Curtis, et al. “Telehealth transformation: COVID-19 and the rise of virtual care.” J Am Med Inform Assoc 27, no. 6 (June 1, 2020): 957–62. https://doi.org/10.1093/jamia/ocaa067.
Schettini, Priscille, Kevin P. Shah, Colin P. O’Leary, Malhar P. Patel, John B. Anderson, Alex H. Cho, Andrea L. Long, Hayden B. Bosworth, and C Blake Cameron. “Keeping care connected: e-Consultation program improves access to nephrology care.” J Telemed Telecare 25, no. 3 (April 2019): 142–50. https://doi.org/10.1177/1357633X17748350.
Foster, Yevgeniya, Michael J. Grant, Samantha M. Thomas, Blake Cameron, Doug Raiff, Kelly Corbet, Christopher Ferreri, and Mitchell E. Horwitz. “Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function.” In Blood, 132:4594–4594. American Society of Hematology, 2018. https://doi.org/10.1182/blood-2018-99-113189.
Green, J. A., P. L. Ephraim, F. F. Hill-Briggs, T. Browne, T. S. Strigo, C. L. Hauer, R. A. Stametz, et al. “Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial.” Contemp Clin Trials 73 (October 2018): 98–110. https://doi.org/10.1016/j.cct.2018.09.004.
Cameron, Blake, Brian Douthit, and Rachel Richesson. “Data and knowledge standards for learning health: A population management example using chronic kidney disease.” Learn Health Syst 2, no. 4 (October 2018): e10064. https://doi.org/10.1002/lrh2.10064.
Boggan, Joel C., Richard M. Atkins, David Simel, and Blake Cameron. “IDENTIFYING VETERANS AT HIGH-RISK FOR PROGRESSION TO END-STAGE RENAL DISEASE AND OPPORTUNITIES FOR NEPHROLOGY REFERRAL.” In Journal of General Internal Medicine, 32:S213–S213. SPRINGER, 2017.
Crowley, Matthew J., Clarissa J. Diamantidis, Jennifer R. McDuffie, C Blake Cameron, John W. Stanifer, Clare K. Mock, Xianwei Wang, et al. “Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.” Ann Intern Med 166, no. 3 (February 7, 2017): 191–200. https://doi.org/10.7326/M16-1901.